206 related articles for article (PubMed ID: 38269517)
21. Recent advances in curcumin nanoformulation for cancer therapy.
Lee WH; Loo CY; Young PM; Traini D; Mason RS; Rohanizadeh R
Expert Opin Drug Deliv; 2014 Aug; 11(8):1183-201. PubMed ID: 24857605
[TBL] [Abstract][Full Text] [Related]
22. Enhancing Therapeutic Efficacy of Curcumin: Advances in Delivery Systems and Clinical Applications.
Omidian H; Wilson RL; Chowdhury SD
Gels; 2023 Jul; 9(8):. PubMed ID: 37623051
[TBL] [Abstract][Full Text] [Related]
23. Curcumin Nanoformulations for Colorectal Cancer: A Review.
Wong KE; Ngai SC; Chan KG; Lee LH; Goh BH; Chuah LH
Front Pharmacol; 2019; 10():152. PubMed ID: 30890933
[TBL] [Abstract][Full Text] [Related]
24. Curcumin in the treatment of liver cancer: From mechanisms of action to nanoformulations.
Shelash Al-Hawary SI; Abdalkareem Jasim S; M Kadhim M; Jaafar Saadoon S; Ahmad I; Romero Parra RM; Hasan Hammoodi S; Abulkassim R; M Hameed N; K Alkhafaje W; Mustafa YF; Javed Ansari M
Phytother Res; 2023 Apr; 37(4):1624-1639. PubMed ID: 36883769
[TBL] [Abstract][Full Text] [Related]
25. Novel curcumin oral delivery systems.
Kurita T; Makino Y
Anticancer Res; 2013 Jul; 33(7):2807-21. PubMed ID: 23780965
[TBL] [Abstract][Full Text] [Related]
26. Potential Therapeutic Targets of Curcumin, Most Abundant Active Compound of Turmeric Spice: Role in the Management of Various Types of Cancer.
Almatroodi SA; Syed MA; Rahmani AH
Recent Pat Anticancer Drug Discov; 2021; 16(1):3-29. PubMed ID: 33143616
[TBL] [Abstract][Full Text] [Related]
27. Curcumin Based Drug Delivery Systems for Cancer Therapy.
Tiwari A; Jain SK
Curr Pharm Des; 2020; 26(42):5430-5440. PubMed ID: 32348207
[TBL] [Abstract][Full Text] [Related]
28. Antitumor Activity of Curcumin in Glioblastoma.
Walker BC; Mittal S
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33322413
[TBL] [Abstract][Full Text] [Related]
29. Targeted therapies of curcumin focus on its therapeutic benefits in cancers and human health: Molecular signaling pathway-based approaches and future perspectives.
Islam MR; Rauf A; Akash S; Trisha SI; Nasim AH; Akter M; Dhar PS; Ogaly HA; Hemeg HA; Wilairatana P; Thiruvengadam M
Biomed Pharmacother; 2024 Jan; 170():116034. PubMed ID: 38141282
[TBL] [Abstract][Full Text] [Related]
30. The Nanotech Potential of Curcumin in Pharmaceuticals: An Overview.
Pardeshi S; Mohite P; Rajput T; Puri A
Curr Drug Discov Technol; 2024; 21(2):e260723219113. PubMed ID: 37493163
[TBL] [Abstract][Full Text] [Related]
31. Redox nanoparticles inhibit curcumin oxidative degradation and enhance its therapeutic effect on prostate cancer.
Thangavel S; Yoshitomi T; Sakharkar MK; Nagasaki Y
J Control Release; 2015 Jul; 209():110-9. PubMed ID: 25912409
[TBL] [Abstract][Full Text] [Related]
32. Therapeutic potential of curcumin and its nanoformulations for treating oral cancer.
Mukherjee D; Krishnan A
World J Methodol; 2023 Jun; 13(3):29-45. PubMed ID: 37456978
[TBL] [Abstract][Full Text] [Related]
33. Curcumin a Natural Phenol and Its Therapeutic Role in Cancer and Photodynamic Therapy: A Review.
Kah G; Chandran R; Abrahamse H
Pharmaceutics; 2023 Feb; 15(2):. PubMed ID: 36839961
[TBL] [Abstract][Full Text] [Related]
34. Potential Role of Curcumin and Its Nanoformulations to Treat Various Types of Cancers.
Kabir MT; Rahman MH; Akter R; Behl T; Kaushik D; Mittal V; Pandey P; Akhtar MF; Saleem A; Albadrani GM; Kamel M; Khalifa SAM; El-Seedi HR; Abdel-Daim MM
Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33800000
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics and pharmacodynamics of curcumin.
Sharma RA; Steward WP; Gescher AJ
Adv Exp Med Biol; 2007; 595():453-70. PubMed ID: 17569224
[TBL] [Abstract][Full Text] [Related]
36. PNIPAAm-MAA nanoparticles as delivery vehicles for curcumin against MCF-7 breast cancer cells.
Zeighamian V; Darabi M; Akbarzadeh A; Rahmati-Yamchi M; Zarghami N; Badrzadeh F; Salehi R; Mirakabad FS; Taheri-Anganeh M
Artif Cells Nanomed Biotechnol; 2016; 44(2):735-42. PubMed ID: 25819738
[TBL] [Abstract][Full Text] [Related]
37. Curcumin nanoformulations: a review of pharmaceutical properties and preclinical studies and clinical data related to cancer treatment.
Naksuriya O; Okonogi S; Schiffelers RM; Hennink WE
Biomaterials; 2014 Mar; 35(10):3365-83. PubMed ID: 24439402
[TBL] [Abstract][Full Text] [Related]
38. Bringing Curcumin to the Clinic in Cancer Prevention: a Review of Strategies to Enhance Bioavailability and Efficacy.
Mahran RI; Hagras MM; Sun D; Brenner DE
AAPS J; 2017 Jan; 19(1):54-81. PubMed ID: 27783266
[TBL] [Abstract][Full Text] [Related]
39. Targeting Cancer using Curcumin Encapsulated Vesicular Drug Delivery Systems.
Hardwick J; Taylor J; Mehta M; Satija S; Paudel KR; Hansbro PM; Chellappan DK; Bebawy M; Dua K
Curr Pharm Des; 2021; 27(1):2-14. PubMed ID: 32723255
[TBL] [Abstract][Full Text] [Related]
40. Plasma proteins interaction with curcumin nanoparticles: implications in cancer therapeutics.
Yallapu MM; Ebeling MC; Jaggi M; Chauhan SC
Curr Drug Metab; 2013 May; 14(4):504-15. PubMed ID: 23566382
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
